Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis.

[1]  J. Andrews,et al.  Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial , 2019, JAMA.

[2]  C. Kelly,et al.  Fecal Transplant in Inflammatory Bowel Disease. , 2017, Gastroenterology clinics of North America.

[3]  D. Relman,et al.  Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients , 2017, bioRxiv.

[4]  P. Moayyedi,et al.  Faecal microbiota transplantation for Clostridium difficile‐associated diarrhoea: a systematic review of randomised controlled trials , 2017, The Medical journal of Australia.

[5]  M. Kamm,et al.  Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial , 2017, The Lancet.

[6]  E. Zoetendal,et al.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. , 2015, Gastroenterology.

[7]  M. Surette,et al.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Gastroenterology.

[8]  Tariq Ahmad,et al.  Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  E. Hohmann Case 25-2014: A man with ulcerative colitis and bloody diarrhea. , 2014, The New England journal of medicine.

[10]  K. Kolho,et al.  Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report. , 2014, Journal of Crohn's & colitis.

[11]  P. Rutgeerts,et al.  Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.

[12]  S. Lynch,et al.  Role of the microbiota in inflammatory bowel diseases. , 2012, Inflammatory bowel diseases.

[13]  S. Schreiber,et al.  Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial , 2011, Gut.

[14]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[15]  J. Bennet,et al.  TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORA , 1989, The Lancet.